Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase
about
Activation of an olfactory receptor inhibits proliferation of prostate cancer cellsNeuroendocrine differentiation in prostate cancerMechanisms of resistance in castration-resistant prostate cancer (CRPC)SRC: marker or actor in prostate cancer aggressivenessThe role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cellsInteraction between tyrosine kinase Etk and a RUN domain- and FYVE domain-containing protein RUFY1. A possible role of ETK in regulation of vesicle traffickingExpression and functional role of orphan receptor GPR158 in prostate cancer growth and progressionSuppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cellsProline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significanceNeuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling.CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylationDasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinasesThe neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitorThe molecular basis for ethnic variation and histological subtype differences in prostate cancer.Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.Targeted therapy in prostate cancer.Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth.Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.Autophagy as a modulator and target in prostate cancer.Neural regulation of hematopoiesis, inflammation, and cancer.A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.G proteins in cancer: the prostate cancer paradigm.The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptorPSA regulates androgen receptor expression in prostate cancer cells.Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapyClinical implications of neuroendocrine differentiation in prostate cancer.Nonreceptor tyrosine kinases in prostate cancer.Posttranslational modification of the androgen receptor in prostate cancer.Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.Oncogenic activation of androgen receptor.Src controls castration recurrence of CWR22 prostate cancer xenografts.Molecular mechanisms of castration-resistant prostate cancer progression.SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner
P2860
Q24318917-CFEDE9B2-4C9C-4693-B914-3F5213E9DF75Q24657547-F83FC0DD-3B21-426C-95C1-73A390484126Q26774221-4BCD67CA-03E0-4FFF-A50A-AEEFEE862DD5Q27012541-146AC992-41E4-471B-AEE6-7A2863E090DDQ28191639-F0A129A2-A52E-47F0-85EB-3D279FFFFB27Q28205058-65CF79CB-DD1B-4419-956C-E42CCCFF21E6Q28257270-11D0535B-5E3E-4799-B1E8-345EA5189372Q28265036-F8DBCBAB-69C0-464D-B0DA-F6AA876413E5Q28280935-284FCC7E-483E-4646-8FB1-490EBEB1895FQ28474456-FF3C1565-D46B-4806-9711-25D328065703Q30412002-E48C16BB-54CD-4606-B086-D595C22C03AEQ30429511-30C4EA49-FCE9-4390-BA82-427273013110Q30433918-0B2820A6-1280-4060-890A-077DA312114BQ30434799-066286D4-FB4B-46E4-BDB0-87E00C543187Q30441092-95118EE4-465A-4BCC-819C-A3A3CA27601BQ30661625-F7572BDB-2BC2-41F0-B3A7-8D3710B1EC49Q33835864-FC62635B-7C7E-48E9-956D-B26243BB27C9Q34483541-3FBBCAD5-83FC-40B0-8549-E88685F2DEA9Q34487820-DA29E6F7-D84E-45AA-9FE6-AC7D7A338A83Q34634763-C17813C8-31FD-4057-99FC-C035A476E34FQ34714834-E3EB5505-077D-438D-851C-48BB592FD515Q34959208-CF320B72-91BA-499A-ACE7-C2614E682E7DQ35163061-F41EE3C9-AB8E-4430-89DE-777A67C24DA7Q35207623-B018430C-2A44-492E-AE72-F682751C58C2Q35557084-CCB3FE0E-32D7-4B12-B719-E3A9284F6B17Q35560457-75D33D11-AFBB-438E-822B-D94867BD512CQ35576853-A4E5A03E-71BE-4A9D-884C-8FC2F3600DE0Q35634255-02317D42-CC72-42F3-9257-23E749F5CCC2Q35838409-2CD677E2-C0D5-4020-A981-DD7B74ECB8AAQ36114365-411D793A-A49D-46F2-9A83-E7825D9F755FQ36272854-A6E0F3C8-4AFD-4C17-94C4-8FC5CBFD5EA4Q36540348-7E02C921-E89C-414C-AFC5-58BCDB8233EEQ36639877-0A5996A9-E551-4012-8A8E-A6AD3F990904Q36759212-284795C1-AD5B-4B36-891A-9EC05BA46315Q37092022-701A2DB0-90C4-4DE7-90AC-0712FBFFC810Q37187646-BF225ADE-7B71-4292-88C0-954F98349CBDQ37359265-43958EA9-30E8-4431-9339-3CE981C2A8FDQ37481145-5FCB5DFE-1EBF-466D-83EC-DF2B6710D631Q37630578-6C8D5960-649F-45B0-88B5-8715D1F7D073Q37662776-992EA9C3-4E5C-444D-9238-8498C4A9D568
P2860
Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@ast
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@en
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@nl
type
label
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@ast
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@en
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@nl
prefLabel
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@ast
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@en
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@nl
P2093
P2860
P1476
Neuropeptide-induced androgen ...... Src, and focal adhesion kinase
@en
P2093
P2860
P304
P356
10.1128/MCB.21.24.8385-8397.2001
P407
P577
2001-12-01T00:00:00Z